Click here to view the complete Medical Technology conference brochure

Attending Companies •AdvaMed •Becton, Dickinson & Co. •Cambridge Heart •CeMines •Citigroup Asset Management •Computer Motion •Domain Assoc. •Feldman Weinstein LLP •Guidant Corp. •Kensey Nash •LaunchCyte •Leerink Swann  •Medical Device Consultants •Medical Device Daily •Medtech Insight •NJ Institute of Technology •NYU Downtown Hospital •Orthofix Intl.  •Percardia Inc. •Peterson Consulting •Physiometrix •Prism Venture Partners •Polymerix Corp. •Sanford C. Bernstein & Co. •Wachovia Securities ...and more

8:00 am  
Registration & Breakfast

9:00 am  
Conference Introduction

9:15 am 
CEO Roundtable: BREAKTHROUGH TECHNOLOGIES SHAPING THE FUTURE OF MEDICINE 
Join a distinguished panel of guests to discuss the shape the future of medical devices may take. Currently, U.S. medical device and diagnostics manufacturers account for $75 billion, or 47% of the world's total. Industry insiders analyze the landscape of this market and identify areas with largest potential growth and future profits.
• What new products are in the pipeline for the next few years - and beyond?
• How will ‘combo’ products affect the industry as a whole?.
• Which products are tipped to have largest economic impact?
• Discover what the future holds in non- or minimally-invasive surgeries?
• How will demographics affect R&D’s focus?

Panelists:
Bailey Dotson
Chief Executive Officer
CeMines

James Binch
Chief Executive Officer
Memry Corporation

Vincent A. Forlenza
Senior Vice President-Technology, Strategy & Development
Becton, Dickinson & Company

Dr. Jonathan Kaufman 
Chief Scientific Officer
LaunchCyte

Dana Mead 
Vice President Corporate Relations and Policy
Guidant Corporation

Moderator:
Sharon O'Reilly
President
Medtech Insight

10:00 am 
Audience Q & A

10:15 am 
Sponsored Presentation

10:35 am 
Networking Break

10:50 am  
HOW & WHY TO INITIATE THE M&A WALTZ
• Gain insight into partnering or developing strategic alliances with corporate ventures.
• Learn which type of company is optimal to partner with.
• Corporate Development - is your best strategy a buyout?

Panelists:
Nancy Briefs
President
Percardia Inc.

Charles Federico 
Chief Executive Officer
Orthofix International

Joseph Bossong 
Director, Healthcare Investment Banking
Wachovia Securities

John L. Brooks, III  
General Partner
Prism Venture Partners

Moderator:  
Joseph Smith
Partner
Feldman Weinstein LLP

11:35 am   
SURGICAL ROBOTICS - CREATING A NEW ERA OF PATIENT AND PHYSICIAN FRIENDLY SURGERY. 
Computer Motion is the world's leading developer of surgical robotic
systems, serving over 900 customers and 3000 surgeons in 32 countries around the world. Together with its surgeon partners the company is creating a new era of patient and physician friendly surgery. The company develops, manufactures and markets proprietary computer and robotic surgical systems for the operating room that enhance surgeons' capabilities, improve outcomes
and reduce costs.

Speaker: 
Robert W. Duggan
Chief Executive Officer
Computer Motion, Inc.

11:55 am  
Industry Roundtable: EXPLORING FINANCING OPPORTUNITIES FOR MEDICAL TECHNOLOGY COMPANIES
• What are the most attractive ways to raise capital in today's economy?
• Gain insight into partnering or developing strategic alliances with corporate ventures.
• Learn which type of company is optimal to partner with.
• Understand tech transfer and incubators can prove beneficial.
• Acquisitions - is your best exit strategy a buyout?

Panelists:
Joseph Kaufmann 
Chief Executive Officer
Kensey Nash Corporation

Dr. Michael Jaffe,  
Medical Device Concept Laboratory Director
New Jersey Institute of Technology

Brad Wilds 
Portfolio Manager
Citigroup Asset Management

Stuart Barich
Managing Director
Leerink Swann & Co.

Jesse I. Treu
General Partner
Domain Associates, LLC

Moderator:  
John Williams
Chief Executive Officer
Physiometrix

12:40 pm 
Audience Q & A

12:55 pm  
Luncheon for Speakers & Delegates  
with Keynote Speaker

Keynote Speaker: INSIDER VIEW OF CLINICAL TRIALS

Speaker:
Dr. Michael Feldstein, PhD
Director Clinical Services
Medical Device Consultants, Inc.

2:30 pm  
POLYMERDRUGS™ -  
A NEW TWIST ON BIOMATERIALS
Polymerix Corporation is a specialty pharmaceutical company developing PolyAspirin, an anti-inflammatory/antiseptic polymer for cardiovascular stents and orthopedic/surgical products, with additional applications in pharmaceutical drug delivery. PolyAspirin is the first of a new class of PolymerDrugs that are uniquely made of drug molecules, which are generated as the polymers slowly degrade in the body.

Speaker:
Dr. Robert F. Butz
President
Polymerix Corporation

2:50 pm 
One-on-One Analyst Interview: 
WALL STREET ASSESSES THE INDUSTRY
Hear directly from an analyst on the marketplace and preferred stock selections and ask your questions about specific companies, technologies and forecasts.

Analyst:
Bruce Nudell, Ph.D.
Senior Research Analyst
Sanford C. Bernstein & Company

Interviewer: 
Andrew Pickup
Publisher
The Wall Street Transcript

3:15 pm 
Networking Break

3:30 pm  
WHAT THE CHANGES AT THE FDA MEAN
FOR YOU & YOUR COMPANY
• Review of legislative reforms and their effect on the agency.
• What the changes in management at the FDA mean for the industry.
• Developments related to the FDA and CMS interaction.

Speaker:
Blair Childs
Executive Vice President
AdvaMed

3:50 pm  
CEO Roundtable: TOTAL COST OF TREATMENT & EFFECTIVE REIMBURSEMENT STRATEGIES
Developing an effective reimbursement strategy is as important as getting FDA approval to success. Your device may offer amazing benefits, but if Medicaid or insurance companies won't reimburse hospitals for it, you'll face extreme difficulties convincing the medical profession to adopt your product, regardless of its quality. 
• When should your reimbursement strategy be developed?
• Ensure your products are cost-effective enough to be attractive to the payors.
• Learn effective methods to acquire reimbursement early on.
• Gain insight into how new technologies will be reimbursed.

Panelists:
David J. Chazanovitz
President & Chief Executive Officer
Cambridge Heart

Ronald Podraza
Chief Executive Officer
Reimbursement Principles

Allan Fine  
Principal
Peterson Consulting

Moderator:
Jim Stommen
Editor-In-Chief
Medical Device Daily

4:40 pm 
Audience Q & A

4:55 pm  
Networking Reception
Your opportunity to meet with presenters and fellow attendees.

*Agenda subject to change